- Selling to a Market familiar with Herbal Remedies
- China holds the most cannabis patents in the world
- China produces the most industrial hemp in the world
With a history that stretches back into the mists of time, it will be no surprise to learn that, in China, the virtues of cannabis sativa L. have been known for millennia. Used as a fiber, as food and in medicine, references to the plant appear throughout classical Chinese literature. Today, the same enterprising spirit that developed cannabis cures in traditional Chinese medicine continues. Chinese entrepreneurs and researchers hold hundreds of patents related to cannabis, and the cannabis ecosystem is at its most vibrant in China. Now, CD International Enterprises, Inc. (OTC: CDII) plans to make this rich body of traditional medicine and modern innovation available outside China. Standing at the nexus between East and West, the company is gearing up to market CBD cures to customers in China and to the many Chinese-speaking communities dotted around the world. In addition, it plans to distribute bulk cannabidiol (CBD) crystal in the U.S.
The influence of cannabis on Chinese society and industry is evident everywhere, for it is the same plant, cannabis sativa, that produces both marijuana, for medicinal use, and hemp, for industrial purposes. When intended for industry, strains of the plant are grown for the hemp stalk, which is the longest and strongest of all natural fibers. These fiber-rich biotypes of cannabis (hemp) were extensively employed in ancient China to make paper, rope and fishing nets, for example. Hemp seed provides an added benefit, since it is high in protein, amino acids, essential fatty acids and vitamins. Other strains, developed for their abundance of seed and inflorescence (flowers), produce marijuana. The Chinese, who have long embraced homeopathic and natural remedies, have been using the achenes (seeds) for close to two thousand years. This is in contrast to applications in Western medicine that are, typically, derived from the female flowering tops.
All cannabis contains delta-9 tetrahydrocanabinol (THC), a psychoactive substance responsible for the “high” when marijuana is smoked or otherwise ingested, but, since THC is produced in the resin glands of the plant’s flowers and buds, the amount of THC in plants grown as hemp for their stalks is negligible, by all accounts not large enough to affect mental functions. Hemp also contains another cannabinoid, known as cannabidiol, which is believed to have a number of therapeutic benefits. CBD has been used to treat diabetes, rheumatoid arthritis, cancer, epilepsy, antibiotic-resistant infections, alcoholism, PTSD and neurological disorders.
In April 2017, CDII launched a new division to distribute CBD crystal in the U.S. and CBD-based products to the Chinese-speaking population. The launch of Green Products Distribution and the associated online store is a key part of CDII’s expansion plans, which are currently underway. The company’s primary goal with this launch is to retail CBD-based products to Chinese-speaking communities, which collectively represent a potential global market of over 1.6 billion people.
The CBD crystal distributed by CDII is manufactured in China and processed from industrial hemp. China is the world’s largest producer of hemp fiber and the second largest producer, after France, of hemp seed. Indeed, most of the hemp used in the U.S., where its cultivation is prohibited, is imported from China. Consequently, CDII avoids all the legal complications associated with ‘touching’ THC, which is illegal in China and, by federal law, in the U.S.
Unlike, the U.S., however, China has never restricted the cultivation or use of hemp. In fact, the government there has encouraged farming and research. Chinese individuals and companies now hold more than half (309) of the 606 patents related to cannabis recorded by the Intellectual Property Organization (WIPO).
These are all the factors that makes CDII’s CBD venture, Green Products Distribution, look promising. The company has already entered into a wholesale distribution agreement with GWR Distributors, a world-leading supplier of CBD-based products derived from hemp.
For more information, visit the company’s website at www.CDII.net
About QualityStocks
QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. It is part of our mission statement to help the investment community discover emerging companies that offer excellent growth potential. We offer several ways for investors to learn more about investing in these companies as well as find and evaluate them.
QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com
Please see full terms of use and disclaimers on the QualityStocks website applicable to all content provided by QS, wherever published or re-republished: http://www.qualitystocks.net/disclaimer.php
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment